Assessing and Treating Patients With Sleep/Wake Disorders

Sleep Medicine: Diagnostic Frontiers

Sleep-Wake Disorders present as systemic health threats linked to hypertension, metabolic syndrome, and psychiatric instability. Assessment requires distinguishing between disorders of initiation (Insomnia), maintenance (Apnea), and excessive sleepiness (Narcolepsy). This guide provides a structured approach to differential diagnosis and management, integrating physiological data with behavioral interventions.

The American Academy of Sleep Medicine (AASM) provides clinical practice guidelines setting accreditation standards. Clinicians must navigate the complex interplay between circadian biology and environmental stressors.

Insomnia Disorder: Beyond Hygiene

Chronic insomnia involves difficulty initiating or maintaining sleep occurring >3 nights/week for >3 months.

Assessment

Sleep Diary: Patients track bedtimes, wake times, and caffeine intake for 2 weeks.
Screening: Use the Insomnia Severity Index (ISI) to quantify impact.

Treatment: CBT-I

Cognitive Behavioral Therapy for Insomnia (CBT-I):
Sleep Restriction: Limiting time in bed to match actual sleep time, increasing homeostatic sleep drive.
Stimulus Control: Re-associating the bed with sleep only. “If not asleep in 20 mins, leave the bedroom.”

Obstructive Sleep Apnea (OSA)

Repetitive collapse of the upper airway during sleep causes oxygen desaturation and arousal.

Pathophysiology

Risk factors include obesity (neck circumference >17″ men, >16″ women), retrognathia, and male gender. Collapse causes sympathetic activation, spiking blood pressure.

Diagnosis

STOP-BANG Questionnaire: High sensitivity screening.
Polysomnography (PSG): Definitive test. Measures Apnea-Hypopnea Index (AHI). AHI > 5 is diagnostic; > 30 is severe.

Management

CPAP: Continuous Positive Airway Pressure splints the airway open.
Alternatives: Mandibular Advancement Devices (dental appliances) for mild/moderate cases. Hypoglossal Nerve Stimulation (implant) for CPAP intolerance.

Narcolepsy: Hypocretin Deficiency

A neurological disorder of sleep-wake regulation.

Key Symptoms (Tetrad)

1. Excessive Daytime Sleepiness (EDS): Irresistible sleep attacks.
2. Cataplexy: Sudden loss of muscle tone triggered by emotion (laughter). Unique to Type 1.
3. Sleep Paralysis: Inability to move upon waking.
4. Hypnagogic Hallucinations: Vivid dreams at sleep onset.

Management

Pharmacology: Stimulants (Modafinil) for EDS. Sodium Oxybate (Xyrem) for cataplexy/sleep consolidation.
Behavioral: Scheduled naps (15-20 mins).

Parasomnias: Abnormal Behaviors

NREM Parasomnias: Occur in deep sleep. Sleepwalking (Somnambulism), Sleep Terrors. Patient has no memory of event.
REM Parasomnias: REM Sleep Behavior Disorder (RBD). Acting out dreams due to loss of muscle atonia. Strong predictor of neurodegenerative disease (Parkinson’s/Lewy Body).

Sleep-Related Movement Disorders

Restless Legs Syndrome (RLS): Urge to move legs, worsening at rest/night. Linked to iron deficiency (Ferritin < 50 ng/mL) or dopamine dysfunction. Rx: Iron, Gabapentinoids.
Periodic Limb Movement Disorder (PLMD): Repetitive limb movements during sleep causing arousal. Diagnosed via PSG.

Pharmacologic Management Nuances

Benzodiazepine Receptor Agonists (Z-drugs): Zolpidem/Eszopiclone. Effective for onset but risk of dependence and complex sleep behaviors.
Dual Orexin Receptor Antagonists (DORAs): Suvorexant/Lemborexant. Block wakefulness rather than inducing sedation. Safer profile for elderly/cognitive impairment.

Circadian Rhythm Disorders

Mismatch between internal clock and external environment.
Delayed Sleep Phase: “Night owls.” Common in teens. Rx: Morning bright light.
Shift Work Disorder: Insomnia/sleepiness due to non-standard hours. Rx: Melatonin, light management.

FAQs: Sleep Disorders

Conclusion

Sleep disorders are complex but treatable. By mastering differential diagnosis between insomnia, apnea, and hypersomnolence, clinicians restore the vital restorative function of sleep, improving systemic health outcomes.